Bayer Vital GmbH secures contract for Pharmaceutical Products - Agreement in accordance with Section 130a (8) SGB V I V M * 130c Paragraph 1 SGB V for the active ingredient acoramiidis (Beyonttra(R))

Germany, April 24 -- Germany based Bayer Vital GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical Products - Agreement in accordance with Section 130a (8) SGB V I V M * 130c Paragraph 1 SGB V for the active ingredient acoramiidis (Beyonttra(R)). The value of the contract is worth 22100000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....